ARCH and Population Health join China blitz with Haisco deal
ARCH Venture Partners and Population Health Partners are joining the China biotech investment wave through a new deal with Haisco.
Haisco Pharmaceutical
Private
R&D-driven pharmaceutical company focused on new drug development, synthesis, and manufacturing based in Chengdu, China.
Company Info
Clinical Development Pipeline
HSK34890
Target: UndisclosedRecent News
Leadership Team
Wei Wang
Chairman